Page last updated: 2024-12-08

gestonorone caproate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Gestonorone Caproate: A long-acting potent progestogen structurally related to PROGESTERONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1185) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID443881
CHEMBL ID2107389
CHEBI ID31650
SCHEMBL ID147685
MeSH IDM0009215

Synonyms (62)

Synonym
caproato de gestonorona
caproate de gestonorone
u38e620ns6 ,
unii-u38e620ns6
gestonoroni caproas
einecs 215-010-2
17alpha-hydroxy-19-norprogesterone capronate
17alpha-hydroxy-19-norprogesterone caproate
17-alpha-hydroxy-19-norprogesterone caproate
19-norpregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)-
17-alpha-hexanoyloxy-19-nor-4-pregnene-3,20-dione
17-beta-acetyl-17-hydroxyestr-4-ene-3-one hexanoate
gestonorone caproate [usan:inn:jan]
gestonoroni caproas [inn-latin]
17-((1-oxohexyl)oxy)-19-norpregn-4-ene-3,20-dione
ccris 6524
19-nor-17alpha-hydroxyprogesterone caproate
caproato de gestonorona [inn-spanish]
caproate de gestonorone [inn-french]
nsc 84054
17alpha-hydroxy-19norprogesterone-17alpha caproate
gestonorone capronate
primostat
gestronol hexanoate
sh 582
nsc-84054
nsc84054
17.alpha.-hydroxy-19-norprogesterone capronate
1253-28-7
depostat
gestonorone caproate
sh 80582
gestronol caproate
17-hydroxy-19-norpregn-4-ene-3,20-dione hexanoate
17.alpha.-hydroxy-19-norprogesterone caproate
19-norpregn-4-ene-3,20-dione, {17-[(1-oxohexyl)oxy]-}
[(8r,9s,10r,13s,14s,17r)-17-acetyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] hexanoate
17-acetyl-3-oxoestr-4-en-17-yl hexanoate
19-norprogesterone, 17-hydroxy-, hexanoate
19-norpregn-4-ene-3,20-dione, 17-hydroxy-, hexanoate
depostat (tn)
gestonorone caproate (jan/usan)
D01159
gestonorone hexanoate
sh-582
CHEMBL2107389
SCHEMBL147685
gestonorone caproate [mart.]
gestonorone caproate [who-dd]
gestonorone caproate [mi]
gestonorone caproate [jan]
gestonorone caproate [inn]
gestonorone caproate [usan]
CHEBI:31650
HY-U00091
(8r,9s,13s,14s,17r)-17-acetyl-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl hexanoate
DB14677
Q11320734
EN300-19767789
(1r,3as,3br,9ar,9bs,11as)-1-acetyl-11a-methyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl hexanoate
DTXSID40871837
AKOS040740793
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (57)

TimeframeStudies, This Drug (%)All Drugs %
pre-199049 (85.96)18.7374
1990's5 (8.77)18.2507
2000's2 (3.51)29.6817
2010's1 (1.75)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 14.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index14.92 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index4.03 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (14.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials11 (18.03%)5.53%
Reviews4 (6.56%)6.00%
Case Studies4 (6.56%)4.05%
Observational0 (0.00%)0.25%
Other42 (68.85%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]